Chemomab Therapeutics Ltd. Weighted Average Fair Value At Measurement Date Share Options Granted
Chemomab Therapeutics Ltd. (CMMB) had Weighted Average Fair Value At Measurement Date Share Options Granted of $2.60 million as of 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Notes
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted · last filed 2019-04-24
- 2018-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted $2.60M.
- 2017-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted $1.10M.
| Period end | Weighted Average Fair Value At Measurement Date Share Options Granted |
|---|---|
| 2018-12-31 | $2.60M 20-F · filed 2019-04-24 |
| 2017-12-31 | $1.10M 20-F · filed 2019-04-24 |